Showing 7481-7490 of 10276 results for "".
- Dr. Larry Brilliant to Give Keynote at ASDS 2017 Meetinghttps://practicaldermatology.com/news/dr-larry-briiliant-to-give-keynote-at-asds-2017-meeting/2458097/Larry Brilliant, MD, MPH, Chair of the Skoll Global Threats Fund in San Francisco and former Vice President and Executive Director of Google, is slated to give the opening keynote address at The
- Serica: New Formulations Target Scars, Stretch Marks with Rain-forest Sourced Ingredientshttps://practicaldermatology.com/news/serica-new-formulations-target-scars-stretch-marks-with-rain-forest-sourced-ingredients/2458099/Serica Moisturizing Scar Formula and Serica Moisturizing Stretch Mark Formula from Cynova Laboratories, formulated with a special blend of ingredients, including Amazonian Pracaxi oil and a patented network of semipermeable silicones, are intended to help to
- Glenmark Pharmaceuticals Reports Positive Phase 2a Data for GBR 830 for Atopic Dermatitishttps://practicaldermatology.com/news/glenmark-pharmaceuticals-reports-positive-phase-2a-data-for-gbr-830-for-atopic-dermatitis/2458102/Glenmark Pharmaceuticals shared positive data from a Phase 2a study of GBR 830, an investigational, anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis (AD). The study evaluated the safety, biological and clinical activity, and pharmacokinetics of GBR 830, relative to placebo, i
- Valeant Launches Siliq Injection for Psoriasishttps://practicaldermatology.com/news/valeant-launches-siliq-injection-for-psoriasis/2458107/Valeant Pharmaceuticals International, Inc. launched Siliq (brodalumab) Injection during the Summer American Academy of Dermatology (AAD) meeting taking place in New York from July 27-30, 2017. Siliq, a
- Study IDs Risk Factors for Melanoma in Kidney Transplant Recipientshttps://practicaldermatology.com/news/study-ids-risk-factors-for-melanoma-in-kidney-transplant-recipients/2458108/Kidney transplant patients appear to be at a greater risk of developing melanoma than the general population and risk factors include being older, male and white, findings that corroborate results demonstrated in other studies, according to a new article published by
- Early Use of CO2 Lasers on Surgical Scars Bests Silicone Gel Treatmenthttps://practicaldermatology.com/news/early-use-of-co2-lasers-on-surgical-scars-bests-silicone-gel-treatment/2458112/Early treatment of surgical scars with a super-pulsed fractional C02 laser shows promise, new research suggests. The study, which appears in Lasers in Surgery and Medicine (LSM), found that laser treatment of
- Joseph H. Boccuzi Appointed to Allergan plc Board of Directorshttps://practicaldermatology.com/news/joseph-h-boccuzi-appointed-to-allergan-plc-board-of-directors/2458116/Allergan plc has named Joseph H. Boccuzi to its Board of Directors, effective immediately. Mr. Boccuzi recently retired as a Partner in the Global Life Sciences, Board and Chief Executive Officer Practices at Spencer Stuart, following 24 years of service with
- DermTech Secures Billing Codes for its Proprietary Melanoma Testhttps://practicaldermatology.com/news/dermtech-secures-billing-codes-for-its-proprietary-melanoma-test/2458115/The American Medical Association (AMA) has granted DermTech, Inc. Category 1, Tier 2 Molecular Pathology procedure codes related to its proprietary test for the detection of melanoma related gene expression. The company has secured this Common Procedural Terminology (CPT) coding for LINC and PRAM
- Valeant to Sell Obagi Medical Products Business for $190 Mhttps://practicaldermatology.com/news/valeant-to-sell-obagi-medical-products-business-for-190-m/2458117/Valeant Pharmaceuticals International, Inc. has entered into an agreement to sell its Obagi Medical Products business for $190 million in cash to Haitong International Zhonghua Finance Acquisition Fund I, L.P. Limited partners of the Fund include industry veterans in other geographic ma
- Galderma CareConnect Patient Savings Card Program Passes Milestonehttps://practicaldermatology.com/news/galderma-careconnect-patient-savings-card-program-passes-milestone/2458119/The Galderma CareConnect patient savings program has surpassed the mark of 1,000,000 prescriptions filled through its patient access program. Committed to keeping accessibility remarkably simple and saving patients’ money, the company says the program is structured to work at any accredited